Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Verastem (VSTM) Operating Income (2018 - 2025)

Historic Operating Income for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to -$40.7 million.

  • Verastem's Operating Income fell 995.14% to -$40.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$160.2 million, marking a year-over-year decrease of 5308.62%. This contributed to the annual value of -$115.0 million for FY2024, which is 2483.82% down from last year.
  • As of Q3 2025, Verastem's Operating Income stood at -$40.7 million, which was down 995.14% from -$43.8 million recorded in Q2 2025.
  • Verastem's Operating Income's 5-year high stood at -$14.1 million during Q1 2021, with a 5-year trough of -$44.2 million in Q1 2025.
  • For the 5-year period, Verastem's Operating Income averaged around -$24.4 million, with its median value being -$19.8 million (2023).
  • Over the last 5 years, Verastem's Operating Income had its largest YoY gain of 4647.75% in 2021, and its largest YoY loss of 19886.13% in 2021.
  • Verastem's Operating Income (Quarter) stood at -$16.5 million in 2021, then dropped by 2.03% to -$16.8 million in 2022, then fell by 26.49% to -$21.3 million in 2023, then crashed by 48.25% to -$31.6 million in 2024, then decreased by 28.89% to -$40.7 million in 2025.
  • Its Operating Income stands at -$40.7 million for Q3 2025, versus -$43.8 million for Q2 2025 and -$44.2 million for Q1 2025.